KLN Selected by Synmosa as Strategic 4PL Partner for Hong Kong<br>Integrated Pharmaceutical Logistics Solutions to Support Regional Growth
Integrated Pharmaceutical Logistics Solutions to Support Regional Growth
2025-08-18 Hong Kong
KLN Logistics Group Limited (‘KLN’; Stock Code 0636.HK) is pleased to announce the appointment of its pharmaceutical arm, KLN Pharma (Hong Kong) Limited (‘KLN Pharma’), as the fourth-party logistics (4PL) service provider for Synmosa Biopharma (HK) Co., Ltd. (‘Synmosa’) in Hong Kong. Under the agreement, KLN Pharma will oversee the entire supply chain for Synmosa, delivering temperature-sensitive and time-critical logistics solutions.
KLN Pharma will utilise its GMP-compliant facilities, multi-temperature storage capabilities, temperature-controlled fleet and proprietary inventory systems to ensure regulatory compliance and product integrity. The partnership encompasses a full spectrum of logistics services, including inbound logistics, inventory management, order fulfilment, marketing logistics, distribution and regulatory support for Synmosa’s comprehensive array of cardiovascular products.
Samuel Lau, Managing Director - Integrated Logistics Asia of KLN, said, “We are proud to partner with Synmosa, a trusted name in Asian healthcare. Our 4PL model offers the flexibility, compliance, and scalability needed to support Synmosa’s growth in Hong Kong and beyond.”
Peihsuan Lee, Associate Vice-President of Synmosa Biopharma (HK), said, “Synmosa is committed to delivering high-quality, science-backed therapies to patients across Asia. KLN’s logistics expertise and deep understanding of pharmaceutical distribution make them an ideal partner for our Hong Kong operations.”
KLN Pharma has grown rapidly in recent years and its self-owned warehouses, GMP-compliant processes and dedicated healthcare logistics team provide a strong foundation for managing complex supply chains in regulated environments.
- +852 2410 3600
- +852 2480 5958
- corpcom@kln.com
